Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -239,476 | -181,984 | -121,539 | -55,979 | -186,479 |
| Depreciation Amortization | 11,756 | 8,542 | 5,553 | 2,767 | 8,405 |
| Accounts receivable | N/A | -5,574 | -9,351 | -7,551 | N/A |
| Accounts payable and accrued liabilities | 1,767 | 1,072 | 358 | 1,344 | 1,745 |
| Other Working Capital | 104,921 | 105,522 | 113,287 | 122,824 | -306 |
| Other Operating Activity | 37,508 | 33,646 | 27,457 | 13,983 | 18,021 |
| Operating Cash Flow | $-83,524 | $-38,776 | $15,765 | $77,388 | $-158,614 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 230,608 | 230,608 | 169,061 | 147,646 | -231,946 |
| PPE Investments | -37,059 | -29,080 | -20,817 | -4,342 | -39,798 |
| Purchase Sale Intangibles | -300 | -300 | 0 | 0 | N/A |
| Other Investing Activity | -300 | -300 | 0 | 0 | 0 |
| Investing Cash Flow | $193,249 | $201,228 | $148,244 | $143,304 | $-271,744 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -90 | -67 | -44 | -22 | -12,798 |
| Common Stock Issued | 143,711 | N/A | N/A | N/A | 462,901 |
| Other Financing Activity | 10,724 | 7,156 | 4,796 | 2,106 | 8,437 |
| Financing Cash Flow | $154,345 | $7,089 | $4,752 | $2,084 | $458,540 |
| Exchange Rate Effect | -307 | N/A | 0 | 0 | N/A |
| Beginning Cash Position | 295,349 | 295,349 | 295,349 | 295,349 | 267,167 |
| End Cash Position | 559,112 | 464,890 | 464,110 | 518,125 | 295,349 |
| Net Cash Flow | $263,763 | $169,541 | $168,761 | $222,776 | $28,182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,524 | -38,776 | 15,765 | 77,388 | -158,614 |
| Capital Expenditure | -37,059 | -29,080 | -20,817 | -4,342 | -39,798 |
| Free Cash Flow | -120,583 | -67,856 | -5,052 | 73,046 | -198,412 |